|
Volumn 8, Issue 19, 2009, Pages 3073-3077
|
Selectively killing transformed cells through proteasome inhibition
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BORTEZOMIB;
CARFILZOMIB;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
PI 083;
PR 171;
PROTEASOME INHIBITOR;
SALINOSPORAMIDE A;
UNCLASSIFIED DRUG;
BREAST CANCER;
CELL CYCLE REGULATION;
CELL SURVIVAL;
CELL TRANSFORMATION;
CLINICAL TRIAL;
DNA REPAIR;
DRUG MECHANISM;
EPITHELIUM TUMOR;
HUMAN;
INTRACELLULAR KILLING;
LUNG CANCER;
MANTLE CELL LYMPHOMA;
MULTIPLE MYELOMA;
NEUROTOXICITY;
NONHUMAN;
PROTEIN DEGRADATION;
PROTEINASE INHIBITION;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
THROMBOCYTOPENIA;
UBIQUITINATION;
|
EID: 70349934759
PISSN: 15384101
EISSN: 15514005
Source Type: Journal
DOI: 10.4161/cc.8.19.9815 Document Type: Short Survey |
Times cited : (1)
|
References (13)
|